3 They developed a method to identify subpopulations of MSCs that secrete high levels of EVs, an approach that could allow for the selection of more therapeutically active cells for clinical ...
Spirulina has solid potential as a therapeutic adjuvant, according to researchers in Australia who isolated extracellular vesicles (EVs)—nanoscale vesicles enclosed with bilayer phospholipid ...
US-based Aethlon Medical has treated the first subject with its Hemopurifier investigational device in its Australian cancer ...
Aethlon announces first patient enrolled and treated with the Hemopurifier at the Cancer Clinical Trial Unit, CALHN, Royal Adelaide Hospital: San Diego Friday, January 31, 2025, 1 ...